Brandywine Global Investment Management LLC Acquires 26,330 Shares of Globe Life Inc. $GL

Brandywine Global Investment Management LLC raised its holdings in Globe Life Inc. (NYSE:GL) by 36.7% in the fourth quarter, Holdings Channel reports. The firm owned 98,154 shares of the company’s stock after purchasing an additional 26,330 shares during the period. Brandywine Global Investment Management LLC’s holdings in Globe Life were worth $13,728,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after purchasing an additional 607 shares during the period. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares during the period. Goldman Sachs Group Inc. grew its stake in Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after purchasing an additional 58,163 shares during the period. Empowered Funds LLC bought a new position in Globe Life in the 1st quarter valued at $428,000. Finally, Focus Partners Wealth grew its stake in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after acquiring an additional 656 shares during the period. Institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the firm’s stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. This trade represents a 38.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO James Matthew Darden sold 4,663 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the sale, the chief executive officer directly owned 58,451 shares in the company, valued at approximately $8,994,439.88. The trade was a 7.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 105,929 shares of company stock worth $16,382,450. Company insiders own 2.11% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Wells Fargo & Company increased their price target on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, April 10th. Morgan Stanley increased their price target on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, May 21st. Finally, Piper Sandler increased their price target on Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Globe Life has an average rating of “Moderate Buy” and an average target price of $174.11.

Globe Life Stock Performance

Shares of GL opened at $157.23 on Tuesday. The stock’s 50-day simple moving average is $150.83 and its 200 day simple moving average is $143.70. The stock has a market capitalization of $12.21 billion, a price-to-earnings ratio of 10.87 and a beta of 0.49. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $159.36.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the company posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts forecast that Globe Life Inc. will post 15.62 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.